FT News Briefing EMA to probe Sputnik vaccine, Renesas Electronics, Brazil crises
Apr 7, 2021
The EU is set to investigate the ethical standards of clinical trials for the Sputnik V Covid-19 vaccine. Meanwhile, Renesas Electronics faces pressure to diversify amid semiconductor industry challenges. In Brazil, President Bolsonaro grapples with political isolation and the ongoing impact of the pandemic on his leadership. Additionally, businesses are struggling with post-Brexit trade headaches, including a British nematode factory dealing with new export regulations. Global health and technology issues intertwine in a complex narrative.
AI Snips
Chapters
Transcript
Episode notes
EMA Investigates Sputnik V Trials
- The European Medicines Agency (EMA) will investigate Russia's Sputnik V COVID-19 vaccine trials.
- The investigation aims to determine if participants were coerced, impacting the vaccine's approval and reputation.
Renesas Electronics Diversifies
- Renesas Electronics, a major microcontroller chip supplier for cars, is diversifying its business.
- The company seeks to expand into data centers and consumer devices to reduce reliance on the automotive sector.
Bolsonaro's Challenges in Brazil
- Brazil's President Bolsonaro faces political isolation and a severe COVID-19 surge driven by the P1 variant.
- His resistance to lockdowns and reliance on herd immunity are now challenged by the more transmissible variant.